Short term swing trade (A): Chemical stock | Indian stock trading idea on 9 Jun 2026
- June 9, 2026
- 8:15 am
- Goodluck Capital
NOTE
-
Closing Price: ₹2,091 (as of Jun 08, 2026)
-
StopLoss*: Apply on the daily close. After the first target, reset the StopLoss to your buying price.
-
Duration^: Approximate holding period based on the active trading days (excluding market holidays). Actual holding may vary with the market conditions.
-
Upside Potential#: Based on median of the suggested buy range.
Balaji Amines Limited is a leading Indian specialty chemicals company that manufactures methylamines, ethylamines, specialty chemicals, and pharma excipients. Its products are widely used in industries such as pharmaceuticals, agrochemicals, paints, textiles, water treatment, and animal feed. The company also operates a hotel business through Balaji Sarovar Premiere in Solapur. Founded in 1988, Balaji Amines serves both domestic and international markets, exporting to countries across North America, Europe, Asia, Africa, and Latin America.
Earnings Call Summary
- Solid quarter, margins bounced back: Revenue grew 12% YoY to ₹403 crore; EBITDA margin jumped sharply to 25% from 19% a year ago. PAT surged 62% to ₹65 crore, a strong recovery.
- Full year was steady, not spectacular: FY26 revenue was ₹1,454 crore with PAT of ₹169 crore, up 7% YoY. Margins improved but volume growth remained modest due to low capacity utilisation.
- Zero debt, strong balance sheet: Standalone business remains completely debt-free, with net worth growing to ₹2,152 crore. Dividend of ₹11 per share recommended for FY26.
- New products coming in FY27: DME, NMM, and acetonitrile plants are being commissioned in FY27, targeting emerging sectors like battery chemicals. These are new products, not just more of the same.
- Watch out for risks: Capacity utilisation is still low at 35-40%. A large customer is also doing backward integration which could impact methylamines volumes. Government approvals for DME transportation are still pending, which could delay revenue from that segment.
Financial Highlights
| Metric | Q4 FY26 (Mar '26) | Q3 FY26 (Dec '25) | Q4 FY25 (Mar '25) | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue from Operations | 395 | 331 | 353 | ▲ 19.3% | ▲ 11.9% |
| EBITDA (Operating Profit) | 94 | 57 | 60 | ▲ 64.9% | ▲ 56.7% |
| EBITDA Margin (OPM %) | 24% | 17% | 17% | ▲ 700 bps | ▲ 700 bps |
| Net Profit (PAT) | 65 | 31 | 40 | ▲ 109.7% | ▲ 62.5% |
| EPS (₹) | 19.51 | 9.7 | 12.36 | ▲ 101.1% | ▲ 57.8% |
Price Performance

Volume Analysis

Key Observations
- After a steep decline, the stock formed a solid base and developed a double bottom pattern. It first broke above the descending trendline resistance and subsequently crossed the pattern’s neckline, confirming the bullish breakout.
- If buying momentum remains strong, the stock could extend its upward rally in the near term.
Traders following swing trading tips in NSE and BSE stocks watch for breakouts to time their entries.
Technical Image - Daily Timeframe

Oscillators
| Indicator | Value | Zone |
|---|---|---|
| RSI-14 | 70.92 | Overbought |
| CCI-14 | 112.61 | Overbought |
| MFI | 85.32 | Overbought |
| ROC | 14.05 | Positive |
| Stochastic %K | 80.83 | Bullish |
| William %R | -18.12 | Overbought |
Exponential Moving Averages (EMAs)
| EMA | Value | Stock Position |
|---|---|---|
| 5 EMA | 2091 | Above |
| 10 EMA | 2008 | Above |
| 20 EMA | 1856 | Above |
| 50 EMA | 1582 | Above |
| 100 EMA | 1419 | Above |
| 200 EMA | 1373 | Above |
Balaji Amines Stock Price Forecast
Based on our positional trading stocks, the Balaji Amines stock price target will be INR 2222 - INR 2244 in the next 12-14 trading sessions.
MONEY MANAGEMENT AND TRADING RULES
Buy within the recommended price range. You may allow up to 1% flexibility beyond the range if needed.
No need to rush. The recommendation remains valid for up to 7 days, not just at market open.
Use a trailing stop-loss to protect and lock in profits.
Diversify your trading capital across our other recommended stocks to reduce risk.
Invest responsibly. Trade only with funds you can afford to lose and hedge positions where appropriate.
Analyst Summary
The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).
Your Return Could be Much Better
- Swing Trading Advice
- 10—12 swing trade advice / month
- expected upside 6%—8% per trade
- short term trade holding 1-2 weeks
- minimum capital required ₹ 3-lakh
- receive trade advice before 9:00 am
- trade ideas by blackbox system, relied on statistics, technical, fundamental, macroeconomics and sentiment
- Stocks only — no intraday or F&O
1 Month
—
per month
₹ 8000
Price
₹ 8000
3 Months
22% OFF
per month
₹ 6300
₹ 24000
₹ 18900
6 Months
33% OFF
per month
₹ 5300
₹ 48000
₹ 31900
12 Months
50% OFF
per month
₹ 4000
₹ 96000
₹ 48000
all-inclusive pricing. no hidden charges.
Months are referred as calendar months
- e.g. 12 January — 12 April (3 Months)
- 20 June — 20 December (6 Months)
Looking for more information?
Looking for more information?
Swing Trade Advice Benefits
- ideal for short term positional traders
- receive trading advice via Whatsapp
- precise Entry, Target and StopLoss
- preferred largecap & midcap stocks
- revised targets & stoploss if required
- alert message for target or stoploss hit
Swing Trade Advice Samples
-
Buy Piramal Pharma
nse: pplpharma
- Best Buy Range
- Sell Target
- StopLoss
- Potential Upside
- Approx Trade Duration
- : 190 - 194
- : 204 - 207
- : below 180
- : 7% - 8%
- : 12-14 days
-
Buy Le Travenues Technology
nse: ixigo
- Best Buy Range
- Sell Target
- StopLoss
- Potential Upside
- Approx Trade Duration
- : 215 - 220
- : 240 - 240
- : below 195
- : 10% - 13%
- : 14-15 days
-
Buy Privi Speciality Chemicals
nse: priviscl
- Best Buy Range
- Sell Target
- StopLoss
- Potential Upside
- Approx Trade Duration
- : 1845 - 1875
- : 1975 - 2000
- : below 1770
- : 6% - 8%
- : 12-14 days
-
Buy BASF India
nse: basf
- Best Buy Range
- Sell Target
- StopLoss
- Potential Upside
- Approx Trade Duration
- : 5450 - 5600
- : 6050 - 6200
- : below 5200
- : 10% - 12%
- : 12-14 days
-
Buy S H Kelkar
nse: shk
- Best Buy Range
- Sell Target
- StopLoss
- Potential Upside
- Approx Trade Duration
- : 285 - 300
- : 330 - 340
- : below 270
- : 13% - 16%
- : 14-15 days
More Trading & Investment Advice
- Premium (unlocked)
- June 9, 2026
